How I treat diffuse large B-cell lymphoma

por Melchardt, T., Egle, A., Greil, R.
Publicado 2023

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017

por Magnes, Teresa, Egle, Alexander, Greil, Richard, Melchardt, Thomas
Publicado 2017

The Role of Neutrophilic Granulocytes in Philadelphia Chromosome Negative Myeloproliferative Neoplasms

por Kiem, Dominik, Wagner, Sandro, Magnes, Teresa, Egle, Alexander, Greil, Richard, Melchardt, Thomas
Publicado 2021

Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence

por Huemer, Florian, Leisch, Michael, Geisberger, Roland, Melchardt, Thomas, Rinnerthaler, Gabriel, Zaborsky, Nadja, Greil, Richard
Publicado 2020

Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma

por Magnes, Teresa, Wagner, Sandro, Kiem, Dominik, Weiss, Lukas, Rinnerthaler, Gabriel, Greil, Richard, Melchardt, Thomas
Publicado 2021

Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome

por MELCHARDT, THOMAS, WEISS, LUKAS, PLEYER, LISA, STEINKIRCHNER, SUSANNE, AUBERGER, JUTTA, HOPFINGER, GEORG, GREIL, RICHARD, EGLE, ALEXANDER
Publicado 2013

Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial

por Weiss, Lukas, Melchardt, Thomas, Egle, Alexander, Hopfinger, Georg, Hackl, Hubert, Greil, Richard, Barth, Juergen, Rummel, Mathias
Publicado 2017

Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters

por Schlick, Konstantin, Magnes, Teresa, Ratzinger, Lukas, Jaud, Bernhard, Weiss, Lukas, Melchardt, Thomas, Greil, Richard, Egle, Alexander
Publicado 2018

Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy

por Kiem, Dominik, Leisch, Michael, Neureiter, Daniel, Haslauer, Theresa, Egle, Alexander, Melchardt, Thomas, Topp, Max S., Greil, Richard
Publicado 2021

Liver toxicity during temozolomide chemotherapy caused by Chinese herbs

por Melchardt, Thomas, Magnes, Teresa, Weiss, Lukas, Grundbichler, Michael, Strasser, Michael, Hufnagl, Clemens, Moik, Martin, Greil, Richard, Egle, Alexander
Publicado 2014

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia: A case report

por Huemer, Florian, Dejaco, Martin, Grabmer, Christoph, Melchardt, Thomas, Neureiter, Daniel, Mayer, Georg, Egle, Alexander, Greil, Richard, Weiss, Lukas
Publicado 2016

C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients

por Schlick, Konstantin, Magnes, Teresa, Huemer, Florian, Ratzinger, Lukas, Weiss, Lukas, Pichler, Martin, Melchardt, Thomas, Greil, Richard, Egle, Alexander
Publicado 2019

Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Grou...

por Heregger, R., Huemer, F., Hutarew, G., Hecht, S., Cheveresan, L., Kotzot, D., Schamschula, E., Rinnerthaler, G., Melchardt, T., Weiss, L., Greil, R.
Publicado 2021

Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab

por Magnes, T., Melchardt, T., Hufnagl, C., Weiss, L., Mittermair, C., Neureiter, D., Klieser, E., Rinnerthaler, G., Roesch, S., Gaggl, A., Greil, R., Egle, A.
Publicado 2019

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy

por Magnes, Teresa, Melchardt, Thomas, Weiss, Lukas, Mittermair, Christof, Neureiter, Daniel, Klieser, Eckhard, Gampenrieder, Simon, Moser, Gerhard, Gaggl, Alexander, Greil, Richard, Egle, Alexander
Publicado 2017

CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer

por Melchardt, Thomas, Hufnagl, Clemens, Magnes, Teresa, Weiss, Lukas, Hutarew, Georg, Neureiter, Daniel, Schlattau, Alexander, Moser, Gerhard, Gaggl, Alexander, Tränkenschuh, Wolfgang, Greil, Richard, Egle, Alexander
Publicado 2015

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients

por Troppan, K T, Schlick, K, Deutsch, A, Melchardt, T, Egle, A, Stojakovic, T, Beham-Schmid, C, Weiss, L, Neureiter, D, Wenzl, K, Greil, R, Neumeister, P, Pichler, M
Publicado 2014

Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence

por Magnes, T., Wagner, S., Thorner, A.R., Neureiter, D., Klieser, E., Rinnerthaler, G., Weiss, L., Huemer, F., Zaborsky, N., Steiner, M., Weis, S., Greil, R., Egle, A., Melchardt, T.
Publicado 2021

Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer

por Huemer, Florian, Melchardt, Thomas, Tränkenschuh, Wolfgang, Neureiter, Daniel, Moser, Gerhard, Magnes, Teresa, Weiss, Lukas, Schlattau, Alexander, Hufnagl, Clemens, Ricken, Gerda, Höftberger, Romana, Greil, Richard, Egle, Alexander
Publicado 2015

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones

por Melchardt, Thomas, Hufnagl, Clemens, Weinstock, David M., Kopp, Nadja, Neureiter, Daniel, Tränkenschuh, Wolfgang, Hackl, Hubert, Weiss, Lukas, Rinnerthaler, Gabriel, Hartmann, Tanja N., Greil, Richard, Weigert, Oliver, Egle, Alexander
Publicado 2016